blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4183886

EP4183886 - METHOD FOR NUCLEIC ACID AMPLIFICATION [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  15.03.2024
Database last updated on 04.11.2024
FormerGrant of patent is intended
Status updated on  09.11.2023
FormerExamination is in progress
Status updated on  14.07.2023
FormerRequest for examination was made
Status updated on  23.06.2023
FormerThe application has been published
Status updated on  21.04.2023
Most recent event   Tooltip15.03.2024(Expected) grantpublished on 17.04.2024  [2024/16]
Applicant(s)For all designated states
St. Jude Children's Research Hospital, Inc.
262 Danny Thomas Place
Memphis, TN 38105-3678 / US
[2023/21]
Inventor(s)01 / GAWAD, Charles
Germantown, 38139 / US
02 / EASTON, John
Memphis, 38105-3678 / US
03 / GONZALEZ-PENA, Veronica
Memphis, 38105-3678 / US
 [2023/21]
Representative(s)Wichmann, Hendrik
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstraße 2
81541 München / DE
[2024/16]
Former [2023/21]Wichmann, Hendrik
Wuesthoff & Wuesthoff
Patentanwälte PartG mbB
Schweigerstraße 2
81541 München / DE
Application number, filing date22217020.128.01.2019
[2023/21]
Priority number, dateUS201862623471P29.01.2018         Original published format: US 201862623471 P
[2023/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4183886
Date:24.05.2023
Language:EN
[2023/21]
Type: B1 Patent specification 
No.:EP4183886
Date:17.04.2024
Language:EN
[2024/16]
Search report(s)(Supplementary) European search report - dispatched on:EP06.03.2023
ClassificationIPC:C12Q1/68, C12Q1/6806, C12Q1/6827, C12Q1/6844, C12Q1/6855, C12Q1/6858, C12Q1/686, C12Q1/6869, C12P19/34
[2023/21]
CPC:
C40B40/06 (EP,IL,KR); C12Q1/686 (IL,KR,US); C12N15/1093 (IL,US);
C12Q1/6806 (EP,IL); C12Q1/6869 (IL,KR,US); C12Q1/6883 (IL,US);
C12Q2525/186 (IL); C12Q2531/119 (IL); C12Q2535/122 (IL);
C12Q2600/156 (IL,KR,US) (-)
C-Set:
C12Q1/6806, C12Q2525/186, C12Q2531/119, C12Q2535/122 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/30]
Former [2023/21]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERFAHREN ZUR NUKLEINSÄUREAMPLIFIKATION[2023/21]
English:METHOD FOR NUCLEIC ACID AMPLIFICATION[2023/21]
French:PROCÉDÉ D'AMPLIFICATION D'ACIDE NUCLÉIQUE[2023/21]
Examination procedure21.06.2023Amendment by applicant (claims and/or description)
21.06.2023Examination requested  [2023/30]
21.06.2023Date on which the examining division has become responsible
13.07.2023Despatch of a communication from the examining division (Time limit: M04)
22.08.2023Reply to a communication from the examining division
10.11.2023Communication of intention to grant the patent
05.03.2024Fee for grant paid
05.03.2024Fee for publishing/printing paid
05.03.2024Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP19743724.7  / EP3746564
Fees paidRenewal fee
28.12.2022Renewal fee patent year 03
28.12.2022Renewal fee patent year 04
28.12.2022Renewal fee patent year 05
29.01.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO03002736  (ROCHE DIAGNOSTICS GMBH [DE], et al);
 [X]US2006199193  (KOO TAE-WOONG [US], et al);
 [A]US2010330556  (PETER BRIAN JON [US], et al);
 [X]WO2011050000  (UNIV CALIFORNIA [US], et al);
 [A]WO2013177220  (SCRIPPS RESEARCH INST [US], et al);
by applicantUS5001050
 US5198543
 US6432360
 US6485944
 US6511803
 US6565727
 US2003132538
 US2003205632
 US6773566
 US2005118574
 US6911132
 WO2005068656
 US2005179746
 WO2005082098
 US2005260686
 US2005277197
 US6977033
 US6977148
 US2006039823
 US7052244
 WO2006073504
 US2006159962
 US2006164490
 US2006194331
 US7163612
 US2007023292
 US2007064990
 US2007207513
 WO2007120241
 US7328979
 US2008053205
 US2008124252
 US2008151240
 WO2008098236
 US7425431
 WO2008116221
 US2008269068
 WO2008134153
 US2008305481
 US7547380
 US2009192044
 US2009283407
 US2009321262
 US7641779
 US2010096266
 US2011048951
 US8053192
 WO2012142213
 US2013274117
 US8835358
 US9624538
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.